FORTRESS BIOTECH INC - COM (FBIO)

CUSIP: 34960Q109

Q1 2022 13F Holders as of 31 Mar 2022

Type / Class
Equity / COM
Total 13F shares
35,590,426
Share change
+3,276,450
Total reported value
$48,404,672
Put/Call ratio
133%
Price per share
$1.36
Number of holders
77
Value change
+$4,121,988
Number of buys
29
Number of sells
35

Quarterly Holders Quick Answers

What is CUSIP 34960Q109?
CUSIP 34960Q109 identifies FBIO - FORTRESS BIOTECH INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of FORTRESS BIOTECH INC - COM (FBIO) as of Q1 2022

As of 31 Mar 2022, FORTRESS BIOTECH INC - COM (FBIO) was held by 77 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 35,590,426 shares. The largest 10 holders included Nantahala Capital Management, LLC, VANGUARD GROUP INC, BlackRock Inc., Opaleye Management Inc., TANG CAPITAL MANAGEMENT LLC, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, SHIKIAR ASSET MANAGEMENT INC, and CPWM, LLC. This page lists 77 institutional shareholders reporting positions in this security for the Q1 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.